What is Shandong Weigao Blood Purification Products Co Interest Coverage?
Shandong Weigao Blood Purification Products CoSHSE:603014 +1.45%38 Interest Coverage is 385.47 as of Mar. 2026, which is 2% above its 10-year median of 378.64. GuruFocus rates SHSE:603014 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Shandong Weigao Blood Purification Products Co ranks better than 89.03% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shandong Weigao Blood Purification Products Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥143 Mil. Shandong Weigao Blood Purification Products Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0 Mil.
Shandong Weigao Blood Purification Products Co's interest coverage for the quarter that ended in Mar. 2026 was 385.47.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Shandong Weigao Blood Purification Products Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
SHSE:603014'
s Interest Coverage Range Over the Past 10 Years
Min: 3.68 Med: 378.64 Max: 926.51
Current: 557.55
SHSE:603014's Interest Coverage is ranked better than 89.03% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 16.03
vs SHSE:603014: 557.55
Shandong Weigao Blood Purification Products Co (SHSE:603014) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shandong Weigao Blood Purification Products Co Interest Coverage Related Terms
Shandong Weigao Blood Purification Products Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shandong Weigao Blood Purification Products Co Interest Coverage Chart
Shandong Weigao Blood Purification Products Co Annual Data
SHSE:603014 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Shandong Weigao Blood Purification Products Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Blood Purification Products Co Interest Coverage vs Medical Devices & Instruments Industry
Shandong Weigao Blood Purification Products Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Interest Coverage of 385.47 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. This is near median its historical median of 378.64. Over the past decade, Shandong Weigao Blood Purification Products Co's Interest Coverage has ranged from 3.68 to 926.51. According to the industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #51 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 11%.
Is Shandong Weigao Blood Purification Products Co's Interest Coverage too high?
Shandong Weigao Blood Purification Products Co's current Interest Coverage of 385.47 is near median its 10-year median of 378.64. Over the past 10 years, this metric has ranged from a low of 3.68 to a high of 926.51. The Medical Devices & Instruments industry median Interest Coverage is 16.03. Shandong Weigao Blood Purification Products Co's value of 385.47 is 2304.7% above this industry median. Based on the distribution chart, Shandong Weigao Blood Purification Products Co ranks #51 out of 465 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #51 out of 465 companies for Interest Coverage. This places Shandong Weigao Blood Purification Products Co in the top 11% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 16.03. Shandong Weigao Blood Purification Products Co's value of 385.47 is 2304.7% above this benchmark. Historically, Shandong Weigao Blood Purification Products Co's own Interest Coverage has ranged from 3.68 to 926.51 over the past decade. While the company's 10-year median is 378.64 vs. the industry median of 16.03, Shandong Weigao Blood Purification Products Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.03, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Blood Purification Products Co's current Interest Coverage of 385.47 is 2304.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Blood Purification Products Co's current Interest Coverage is 385.47, which is near median its own 10-year median of 378.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Interest Coverage of 385.47. The current Interest Coverage is 385.47, which is near median its 10-year median of 378.64 and 2304.7% above the Medical Devices & Instruments industry median of 16.03. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Interest Coverage is 385.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shandong Weigao Blood Purification Products Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603014 has been successfully added to your 
